(Q38032084)

27 August 2017

title

Biomarkers for acute GVHD: can we predict the unpredictable? (English)

1 reference

27 August 2017

0 references

Y-B Chen

1

1 reference

27 August 2017

C S Cutler

series ordinal

2

1 reference

27 August 2017

language of work or name

English

0 references

publication date

6 August 2012

1 reference

Bone Marrow Transplantation

27 August 2017

published in

1 reference

27 August 2017

volume

48

1 reference

27 August 2017

issue

6

1 reference

27 August 2017

page(s)

755-760

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2012.143

27 August 2017

exact match

0 references

cites work

Soluble interleukin-2 receptor serum levels after allogeneic bone marrow transplantations as a marker for GVHD.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogenic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Soluble interleukin-2 receptor concentration as a biochemical indicator for acute graft-versus-host disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Serum cytokine levels after HLA-identical bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Elevated interleukin (IL)-18 levels during acute graft-versus-host disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Increased hepatocyte growth factor in serum in acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Increased levels of syndecan-1 in serum during acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Granzymes A and B serum levels in allo-SCT

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Expression of CD30 in patients with acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

A prospective study of serum soluble CD30 in allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Lymphocyte homing and homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

A revision of Billingham's tenets: the central role of lymphocyte migration in acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Leukocyte migration and graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

T-Cell Function and Migration — Two Sides of the Same Coin

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

CCL8 is a potential molecular candidate for the diagnosis of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

A controlled trial of natalizumab for relapsing multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

A biomarker panel for acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Plasma biomarkers in graft-versus-host disease: a new era?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Elafin is a biomarker of graft-versus-host disease of the skin

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Fecal calprotectin and alpha-1 antitrypsin predict severity and response to corticosteroids in gastrointestinal graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Early predictors of transplant-related mortality (TRM) after allogeneic bone marrow transplants (BMT): blood urea nitrogen (BUN) and bilirubin

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Pre-emptive therapy of acute graft-versus-host disease: a pilot study with antithymocyte globulin (ATG).

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

A revised day +7 predictive score for transplant-related mortality: serum cholinesterase, total protein, blood urea nitrogen, gamma glutamyl transferase, donor type and cell dose.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.143

7 January 2021

Identifiers

DOI

10.1038/BMT.2012.143

1 reference

Dimensions Publication ID

27 August 2017

1036565271

0 references

1 reference